Ridgeline FIT sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
$129.99
Cerebrolysin is a neuropeptide formulation composed of low-molecular-weight peptides and amino acids derived from enzymatic hydrolysis of porcine (pig) brain proteins.
It is examined in laboratory and preclinical models for associations with neuronal signaling and neurotrophic pathways.
Researchers use Cerebrolysin in laboratory and preclinical models to applied in experimental systems to study neuronal repair signaling and neurobiology.
This product is for research use only and is not intended for human or veterinary therapeutic use.
Cerebrolysin is not a single peptide but a complex mixture of many low-molecular-weight peptides (some < 10 kDa) plus free amino acids.
Among the bioactive fragments are peptides with similarities to growth factors such as NGF (nerve growth factor) and other neurotrophic molecules.
Because of its heterogeneous composition, there is no single molecular formula or defined molecular weight for Cerebrolysin — its activity arises from the combined synergistic effect of the peptide fractions.
Based on preclinical and experimental research, Cerebrolysin has demonstrated:
Neuroprotection & Anti-Excitotoxicity: studied for modulation of excitotoxic signaling and apoptosis pathways in vitro.
Activation of Antioxidant Pathways: examined for associations with antioxidant signaling cascades in experimental models.
Neurotrophic Support: observed modulation of neurotrophic factor signaling in preclinical studies.
Cognitive Function & Recovery: studied for associations with synaptic signaling and cognitive pathway models.
Anti-inflammatory and Immunomodulatory Effects: examined in laboratory models for cytokine and immune signaling modulation.
Seizure Model Neuroprotection: studied in seizure pathway models for associations with neuronal signaling and BDNF expression.
This formulation of Cerebrolysin (60 mg) is for laboratory and scientific research purposes only.
It is not approved for human use in many jurisdictions, and its usage should be limited to controlled preclinical or in vitro experiments.
Reviews
There are no reviews yet.